Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.

Szarewski A, Mesher D, Cadman L, Austin J, Ashdown-Barr L, Ho L, Terry G, Liddle S, Young M, Stoler M, McCarthy J, Wright C, Bergeron C, Soutter WP, Lyons D, Cuzick J.

J Clin Microbiol. 2012 Jun;50(6):1867-73. doi: 10.1128/JCM.00181-12. Epub 2012 Mar 14.

2.

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, Poljak M.

Clin Microbiol Infect. 2015 Sep;21(9):817-26. doi: 10.1016/j.cmi.2015.04.015. Epub 2015 May 1. Review.

3.

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Austin RM, Zhao C.

Cytojournal. 2014 May 22;11:14. doi: 10.4103/1742-6413.132997. eCollection 2014. Review.

4.

A review of the clinical performance of the Aptima HPV assay.

Haedicke J, Iftner T.

J Clin Virol. 2016 Mar;76 Suppl 1:S40-8. doi: 10.1016/j.jcv.2015.10.027. Epub 2015 Nov 6. Review.

Supplemental Content

Write to the Help Desk